Get Premium to unlock powerful stock data
XSWX:BION (Switzerland)  
BB Biotech AG logo

BB Biotech AG

CHF 57.10 (+0.88%) Jul 1
P/E:
At Loss
P/B:
1.01
Market Cap:
CHF 3.15B ($ 3.28B)
Enterprise V:
CHF 3.49B ($ 3.63B)
Volume:
34.66K
Avg Vol (2M):
62.61K
Also Trade In:
Volume:
34.66K
Market Cap CHF:
3.15B
Market Cap $:
3.28B
PE Ratio:
At Loss
Avg Vol (2-Month):
62.61K
Enterprise Value CHF:
3.49B
Enterprise Value $:
3.63B
PB Ratio:
1.01
GF Score:
Year:
EMBED
To
10Y: -%
Above Low: +NaN%
Below High: NaN%
Alerts Website Sources Stock Report
Dataset
Financial Download Tutorials

Business Description

Description
BB Biotech AG is a part of the healthcare sector in Switzerland. Its primary activity includes making investments, especially in the biotechnology market and is one of the largest investors in the field of biotechnology. The focus of the investments is on those listed companies that focus on the development and marketing of novel drugs with a clear value for the health care system. BB Biotech follows a strategy of carefully screening and selecting biotechnology firms with a long-term time horizon and having established products in the marketplace. Geographically it earns key revenue from the Netherlands.
Name Current Vs Industry Vs History
Cash-To-Debt 0.01
Equity-to-Asset 0.9
Debt-to-Equity 0.11
Debt-to-EBITDA N/A
N/A
N/A
Interest Coverage N/A
N/A
N/A
Piotroski F-Score 3/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score 0
Distress
Grey
Safe
Beneish M-Score 0
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC
Name Current Vs Industry Vs History
5-Day RSI 61.76
9-Day RSI 56.63
14-Day RSI 53.3
6-1 Month Momentum % -27.03
12-1 Month Momentum % -35.18

Liquidity Ratio

Name Current Vs Industry Vs History

Financials

XSWX:BION's 30-Y Financials

Guru Trades

See Details
To
EMBED
SAVE

Insider Trades

See Details
To
EMBED
SAVE

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To
EMBED
SAVE
Dividend
To
EMBED
SAVE

Annualized Return %

Symbol 1 Week 1 Month 3 Months 6 Months YTD 1 Year 3 Years 5 Years 10 Years

Total Annual Return %

Symbol 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013

Executives

EMBED

Valuation Box

Year:
EMBED

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil CHF) -396.22
EPS (TTM) (CHF) -7.31
Beta 1.19
Volatility % 17.48
14-Day RSI 53.3
14-Day ATR (CHF) 1.619317
20-Day SMA (CHF) 55.955
12-1 Month Momentum % -35.18
52-Week Range (CHF) 51 - 92.4
Shares Outstanding (Mil) 55.13

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 3
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

BB Biotech AG Filings

Document Form Filing Date
No Filing Data